Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $134,202 | 10 | 74.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,537 | 7 | 13.6% |
| Travel and Lodging | $17,915 | 25 | 10.0% |
| Food and Beverage | $2,353 | 47 | 1.3% |
| Unspecified | $780.00 | 1 | 0.4% |
| Education | $99.00 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $153,412 | 20 | $0 (2024) |
| Lilly USA, LLC | $16,034 | 35 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $4,569 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $3,870 | 14 | $0 (2024) |
| Gilead Sciences, Inc. | $1,210 | 1 | $0 (2019) |
| AbbVie, Inc. | $294.80 | 6 | $0 (2019) |
| Vertex Pharmaceuticals Incorporated | $216.67 | 1 | $0 (2023) |
| Celgene Corporation | $120.00 | 3 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $99.57 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.30 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,884 | 32 | PFIZER INC. ($19,402) |
| 2023 | $18,200 | 16 | PFIZER INC. ($13,200) |
| 2022 | $7,159 | 20 | Lilly USA, LLC ($7,159) |
| 2020 | $780.00 | 1 | PFIZER INC. ($780.00) |
| 2019 | $121,622 | 14 | PFIZER INC. ($118,760) |
| 2018 | $3,121 | 6 | Janssen Biotech, Inc. ($1,703) |
| 2017 | $119.32 | 2 | AbbVie, Inc. ($119.32) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $37.39 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $80.60 | General |
| Category: Immunology | ||||||
| 10/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $105.47 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: Immunology | ||||||
| 07/12/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $88.38 | General |
| Category: Immunology | ||||||
| 05/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $5,312.50 | General |
| Category: Immunology | ||||||
| 05/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: Immunology | ||||||
| 05/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: Immunology | ||||||
| 04/26/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $283.90 | General |
| 04/26/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $261.90 | General |
| 04/26/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $226.75 | General |
| 04/26/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $165.99 | General |
| 04/26/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $139.51 | General |
| 04/26/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 04/26/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $54.96 | General |
| 04/26/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $35.01 | General |
| 04/26/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 04/26/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 04/11/2024 | PFIZER INC. | VELSIPITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,270.00 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 04/11/2024 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Motility Testing | ||||||
| 03/29/2024 | PFIZER INC. | VELSIPITY (Drug) | Travel and Lodging | In-kind items and services | $52.79 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 03/15/2024 | PFIZER INC. | VELSIPITY (Drug) | Travel and Lodging | In-kind items and services | $495.77 | General |
| Category: INFLAMMATION;PAIN | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TOFACITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $780.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 100 | 128 | $95,857 | $11,622 |
| 2022 | 3 | 79 | 90 | $53,764 | $7,088 |
| 2021 | 4 | 85 | 99 | $40,471 | $8,321 |
| 2020 | 2 | 25 | 32 | $13,578 | $3,115 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 39 | $48,117 | $5,485 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 20 | $16,671 | $2,130 | 12.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 25 | 39 | $12,271 | $1,567 | 12.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 14 | $10,906 | $1,358 | 12.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 16 | $7,892 | $1,082 | 13.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $31,375 | $4,120 | 13.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 38 | 49 | $12,005 | $1,541 | 12.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 16 | $10,384 | $1,428 | 13.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 25 | 25 | $13,439 | $2,955 | 22.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 15 | $13,771 | $2,611 | 19.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 35 | 45 | $6,850 | $1,499 | 21.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 14 | $6,411 | $1,257 | 19.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 14 | $10,878 | $2,493 | 22.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 18 | $2,700 | $621.72 | 23.0% |
About Dr. Lea Chen, M.D
Dr. Lea Chen, M.D is a Gastroenterology healthcare provider based in New Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1679732242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lea Chen, M.D has received a total of $179,886 in payments from pharmaceutical and medical device companies, with $28,884 received in 2024. These payments were reported across 91 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($134,202).
As a Medicare-enrolled provider, Chen has provided services to 289 Medicare beneficiaries, totaling 349 services with total Medicare billing of $30,146. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine, Gastroenterology
- Location New Brunswick, NJ
- Active Since 06/08/2008
- Last Updated 07/23/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1679732242
Products in Payments
- XELJANZ (Drug) $120,839
- VELSIPITY (Drug) $32,573
- OMVOH (Drug) $7,596
- STELARA (Biological) $3,734
- Humira (Biological) $267.31
- TREMFYA (Drug) $234.75
- Entyvio (Biological) $39.30
- TALTZ (Drug) $22.90
- ENDOFLIP (Device) $20.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New Brunswick
Dr. Vinod Rustgi, Md, MD
Gastroenterology — Payments: $555,573
Arvind Trindade, Md, MD
Gastroenterology — Payments: $91,569
George Abdelsayed, Md, MD
Gastroenterology — Payments: $43,225
Dr. Avik Sarkar, M.d, M.D
Gastroenterology — Payments: $12,779
Dr. Vishal Jain, Md, MD
Gastroenterology — Payments: $9,858
Dr. Prateek Chapalamadugu, M.d, M.D
Gastroenterology — Payments: $7,913